TREM1 | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Conferences

28 March 2025

AACR 2025 preview – new preclincal approaches abound

Novel targets including Ly6E and LRRC15 feature alongside more popular mechanisms.

Subscribe to TREM1